AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
September 10, 2024 at 13:35 PM EDT
The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual sales in excess of $50B.
